Cardlytics Director Liane Hornsey's RSU Vesting and Common Stock Acquisition

This Form 4 filing reports that Liane Hornsey, a director of Cardlytics, Inc. (CDLX), received 11,000 shares of common stock through the vesting of restricted stock units (RSUs) on May 20, 2026. The RSUs, originally granted on May 20, 2025, vested in full on their one-year anniversary as per the grant terms. Following this transaction, Hornsey now holds 33,326 shares of Cardlytics common stock directly. The RSUs represented a contingent right to receive one share of common stock each, and the transaction was executed at $0 per share price, which is typical for RSU vesting events. This filing demonstrates the director's continued equity compensation and alignment with shareholder interests through stock ownership.